相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Once- versus twice-daily aspirin treatment in patients with essential thrombocytosis
Mads Lamm Larsen et al.
PLATELETS (2019)
Fibrin clot properties independently predict adverse clinical outcome following acute coronary syndrome: a PLATO substudy
Wael Sumaya et al.
EUROPEAN HEART JOURNAL (2018)
Ticagrelor for Secondary Prevention of Atherothrombotic Events in Patients With Multivessel Coronary Disease
Sameer Bansilal et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2018)
Aspirin-free strategies in cardiovascular disease and cardioembolic stroke prevention
Davide Capodanno et al.
NATURE REVIEWS CARDIOLOGY (2018)
The Aspirin Regimens in Essential Thrombocythemia (ARES) phase II randomized trial design: Implementation of the serum thromboxane B2 assay as an evaluation tool of different aspirin dosing regimens in the clinical setting
Valerio De Stefano et al.
BLOOD CANCER JOURNAL (2018)
Ticagrelor plus aspirin for 1 month, followed by ticagrelor monotherapy for 23 months vs aspirin plus clopidogrel or ticagrelor for 12 months, followed by aspirin monotherapy for 12 months after implantation of a drug-eluting stent: a multicentre, open-label, randomised superiority trial
Pascal Vranckx et al.
LANCET (2018)
Type 2 Diabetes, Obesity, and Aspirin Responsiveness
Carlo Patrono et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2017)
What role will the NHS play in the 2017 election?
Ben Page
BMJ-BRITISH MEDICAL JOURNAL (2017)
The impact of medication adherence on clinical outcomes of coronary artery disease: A meta-analysis
Liping Du et al.
EUROPEAN JOURNAL OF PREVENTIVE CARDIOLOGY (2017)
What role will the NHS play in the 2017 election?
Ben Page
BMJ-BRITISH MEDICAL JOURNAL (2017)
On-pump Cardiac Surgery Enhances Platelet Renewal and Impairs Aspirin Pharmacodynamics: Effects of Improved Dosing Regimens
V. Cavalca et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2017)
Inhibition of the platelet P2Y12 receptor for adenosine diphosphate does not impair the capacity of platelet to synthesize thromboxane A2
Mariangela Scavone et al.
EUROPEAN HEART JOURNAL (2016)
2015 ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation Task Force for the Management of Acute Coronary Syndromes in Patients Presenting without Persistent ST-Segment Elevation of the European Society of Cardiology (ESC)
Marco Roffi et al.
EUROPEAN HEART JOURNAL (2016)
Reduction in Ischemic Events With Ticagrelor in Diabetic Patients With Prior Myocardial Infarction in PEGASUS-TIMI 54
Deepak L. Bhatt et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2016)
Ticagrelor for Prevention of Ischemic Events After Myocardial Infarction in Patients With Peripheral Artery Disease
Marc P. Bonaca et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2016)
Platelet Inhibition With Ticagrelor 60 mg Versus 90 mg Twice Daily in the PEGASUS-TIMI 54 Trial
Robert F. Storey et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2016)
Effects of dabigatran on the cellular and protein phase of coagulation in patients with coronary artery disease on dual antiplatelet therapy with aspirin and clopidogrel Results from a prospective, randomised, double-blind, placebo-controlled study
Francesco Franchi et al.
THROMBOSIS AND HAEMOSTASIS (2016)
Long-term Tolerability of Ticagrelor for the Secondary Prevention of Major Adverse Cardiovascular Events A Secondary Analysis of the PEGASUS-TIMI 54 Trial
Marc P. Bonaca et al.
JAMA CARDIOLOGY (2016)
Drug-Free Platelets Can Act as Seeds for Aggregate Formation During Antiplatelet Therapy
Thomas Hoefer et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2015)
Ticagrelor Protects the Heart Against Reperfusion Injury and Improves Remodeling After Myocardial Infarction
Yumei Ye et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2015)
Multiple daily doses of acetyl-salicylic acid (ASA) overcome reduced platelet response to once-daily ASA after coronary artery bypass graft surgery: a pilot randomized controlled trial
J. S. Paikin et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2015)
Long-Term Use of Ticagrelor in Patients with Prior Myocardial Infarction
Marc P. Bonaca et al.
NEW ENGLAND JOURNAL OF MEDICINE (2015)
Association of spontaneous and procedure-related bleeds with short- and long-term mortality after acute coronary syndromes: an analysis from the PLATO trial
Gregory Ducroq et al.
EUROINTERVENTION (2015)
Chronic Treatment With Ticagrelor Limits Myocardial Infarct Size An Adenosine and Cyclooxygenase-2-Dependent Effect
Manjyot K. Nanhwan et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2014)
Hypofibrinolysis in type 2 diabetes: the role of the inflammatory pathway and complement C3
Katharina Hess et al.
DIABETOLOGIA (2014)
2014 ESC/EACTS Guidelines on myocardial revascularization
Stephan Windecker et al.
EUROPEAN HEART JOURNAL (2014)
A Polypill Strategy to Improve Adherence Results From the FOCUS Project
Jose M. Castellano et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2014)
2014 AHA/ACC Guideline for the Management of Patients With Non-ST-Elevation Acute Coronary Syndromes A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines
Ezra A. Amsterdam et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2014)
Evolving pattern of platelet P2Y12 inhibition in patients with acute coronary syndromes
Rajiv R. Joshi et al.
PLATELETS (2014)
COX-2 Protects against Atherosclerosis Independently of Local Vascular Prostacyclin: Identification of COX-2 Associated Pathways Implicate Rgl1 and Lymphocyte Networks
Nicholas S. Kirkby et al.
PLOS ONE (2014)
In vivo prostacyclin biosynthesis and effects of different aspirin regimens in patients with essential thrombocythaemia
Viviana Cavalca et al.
THROMBOSIS AND HAEMOSTASIS (2014)
2013 ACCF/AHA Guideline for the Management of ST-Elevation Myocardial Infarction A Report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines
Patrick T. O'Gara et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2013)
Evaluation of the pharmacokinetics and pharmacodynamics of ticagrelor co-administered with aspirin in healthy volunteers
Renli Teng et al.
PLATELETS (2013)
Fibrin Clot Structure and Platelet Aggregation in Patients with Aspirin Treatment Failure
Sos Neergaard-Petersen et al.
PLOS ONE (2013)
Blockade of the purinergic P2Y12 receptor greatly increases the platelet inhibitory actions of nitric oxide
Nicholas S. Kirkby et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2013)
Biological efficacy of twice daily aspirin in type 2 diabetic patients with coronary artery disease
Jean-Guillaume Dillinger et al.
AMERICAN HEART JOURNAL (2012)
Aspirin-insensitive thromboxane biosynthesis in essential thrombocythemia is explained by accelerated renewal of the drug target
Silvia Pascale et al.
BLOOD (2012)
ESC Guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation
Ph. Gabriel Steg et al.
EUROPEAN HEART JOURNAL (2012)
The recovery of platelet cyclooxygenase activity explains interindividual variability in responsiveness to low-dose aspirin in patients with and without diabetes
B. Rocca et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2012)
Ticagrelor Compared With Clopidogrel by Geographic Region in the Platelet Inhibition and Patient Outcomes (PLATO) Trial
Kenneth W. Mahaffey et al.
CIRCULATION (2011)
In the presence of strong P2Y12 receptor blockade, aspirin provides little additional inhibition of platelet aggregation
P. C. J. Armstrong et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2011)
24-hour time-dependent aspirin efficacy in patients with stable coronary artery disease
Patrick Henry et al.
THROMBOSIS AND HAEMOSTASIS (2011)
Twice daily dosing of aspirin improves platelet inhibition in whole blood in patients with type 2 diabetes mellitus and micro- or macrovascular complications
Galia Spectre et al.
THROMBOSIS AND HAEMOSTASIS (2011)
Antiplatelet effect of once- or twice-daily aspirin dosage in stable coronary artery disease patients with diabetes
Faouzi Addad et al.
INTERNATIONAL JOURNAL OF HEMATOLOGY (2010)
Impaired anti-platelet effect of aspirin, inflammation and platelet turnover in cardiac surgery
Hernan Cohen Arazi et al.
INTERACTIVE CARDIOVASCULAR AND THORACIC SURGERY (2010)
Effects of Aspirin on Clot Structure and Fibrinolysis Using a Novel In Vitro Cellular System
R. A. Ajjan et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2009)
Ticagrelor versus Clopidogrel in Patients with Acute Coronary Syndromes
Lars Wallentin et al.
NEW ENGLAND JOURNAL OF MEDICINE (2009)
Heritability of clot formation, morphology, and lysis - The EuroCLOT study
Angela M. Carter et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2007)
Marked increase of fibrin gel permeability with very low dose ASA treatment
A Antovic et al.
THROMBOSIS RESEARCH (2005)
Risk of cardiovascular events and rofecoxib: cumulative meta-analysis
P Juni et al.
LANCET (2004)
Fast platelet suppression by lysine acetylsalicylate in chronic stable coronary patients. Potential clinical impact over regular aspirin for coronary syndromes
EP Gurfinkel et al.
CLINICAL CARDIOLOGY (2000)
分享论文
